Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Puma Biotechnology (PBYI)
:PBYI
Holding PBYI?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.09Last Year’s EPS
0.26Same Quarter Last Year
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: 1.65%
|Next Earnings Date:Aug 09, 2018
Earnings Call Sentiment|Positive
The earnings call for Q3 2024 presented a strong financial performance with substantial increases in both revenue and net income, driven by NERLYNX sales and significant royalty revenue growth. However, there were concerns about flat total prescriptions and a year-over-year decrease in bottle sales. Despite these challenges, the company's global expansion and strategic initiatives suggest a positive outlook.Company Guidance
During the third quarter of 2024 earnings call for Puma Biotechnology, guidance was provided on several key financial and operational metrics. The company reported total revenue of $80.5 million, with product revenue net from NERLYNX sales at $56.1 million, marking increases from both the previous quarter and the same quarter in the prior year. Royalty revenue saw significant growth, reaching $24.4 million, largely due to expected sales to China by their offshore partner. NERLYNX ex-factory bottle sales were 2,723, reflecting an 8% quarter-over-quarter increase. The company also provided full-year guidance, projecting net product revenue for NERLYNX between $187 million and $190 million, and net income in the range of $15 million to $17 million. Additionally, guidance for the fourth quarter of 2024 included expected NERLYNX net product revenue in the range of $46 million to $48 million and royalty revenues between $3.5 million and $5 million. The gross to net adjustment for Q4 2024 was estimated to be approximately 21% to 22%.Significant Increase in Revenue
Puma reported total revenue for Q3 2024 of $80.5 million, with product revenue net at $56.1 million, up from $44.4 million in Q2 2024.
Strong Royalty Revenue Growth
Royalty revenue in Q3 2024 was $24.4 million, a substantial increase from $2.7 million in Q2 2024 and $4.5 million in Q3 2023.
Increased NERLYNX Sales
NERLYNX ex-factory bottle sales were 2,723 in Q3 2024, representing an approximate 8% quarter-over-quarter increase.
Positive Net Income
Reported net income on GAAP basis was $20.3 million in Q3 2024, compared to a net loss of $4.5 million in Q2 2024.
Global Expansion
NERLYNX received regulatory approval in Algeria and was launched in South Africa and the United Arab Emirates.
---
PBYI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PBYI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $3.03 | $2.88 | -4.95% |
| Aug 01, 2024 | $3.50 | $3.83 | +9.43% |
| May 02, 2024 | $4.96 | $4.86 | -2.02% |
| Feb 29, 2024 | $6.22 | $5.89 | -5.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Puma Biotechnology (PBYI) report earnings?
Puma Biotechnology (PBYI) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Puma Biotechnology (PBYI) earnings time?
Puma Biotechnology (PBYI) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBYI EPS forecast?
PBYI EPS forecast for the fiscal quarter 2024 (Q4) is 0.09.
---